1. Home
  2. Stocks
  3. Neulandlab Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Neuland Laboratories Share Price Neuland Laboratories

    Mid Cap
    ₹6,973.4
    -118.75 (-1.67%)
    28 April, 2024 04:56 BSE: 524558 NSE: NEULANDLABISIN: INE794A01010

    Start SIP in Neuland Laboratories

    Start SIP

    Neuland Laboratories Performance

    Day Range

    • Low 6,818
    • High 7,192
    ₹ 6,973

    52 Week Range

    • Low 2,009
    • High 7,790
    ₹ 6,973
    • Open Price7,092
    • Previous Close7,092
    • Volume30728

    Neuland Laboratories Share Price

    • Over 1 Month +8.03%
    • Over 3 Month +14.4%
    • Over 6 Month +87.48%
    • Over 1 Year +234.26%

    Neuland Laboratories Key Statistics

    P/E Ratio 28.2
    PEG Ratio 0.1
    Market Cap Cr 8,947
    Price to Book Ratio 9.1
    EPS 127.7
    Dividend 0.1
    Relative Strength Index 52.78
    Money Flow Index 66.04
    MACD Signal 203.88
    Average True Range 330.04
    Neuland Laboratories Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 393418363407
    Operating Expenses Qtr Cr 272280266287
    Operating Profit Qtr Cr 12113797120
    Depreciation Qtr Cr 15151413
    Interest Qtr Cr 4424
    Tax Qtr Cr 23322126
    Net Profit Qtr Cr 81896285
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,201
    Operating Expenses Annual Cr 920
    Operating Profit Annual in Cr 271
    Depreciation Cr 53
    Interest Annual Cr 13
    Tax Annual Cr 52
    Net Profit Annual Cr 163
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 239
    Cash from Investing Activity Annual Cr -61
    Cash from Financing Annual Activity Cr -136
    Net Cash Flow Annual Cr 41
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 988
    Fixed Assets Annual Cr 798
    Total Non Current Assets Annual Cr 819
    Total Current Assets Annual Cr 760
    Total Assets Annual Cr 1,579
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 766
    ROE Annual % 17
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 24
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 393418363407
    Operating Expenses Qtr Cr 272280266287
    Operating Profit Qtr Cr 12113797120
    Depreciation Qtr Cr 15151413
    Interest Qtr Cr 4424
    Tax Qtr Cr 23322126
    Net Profit Qtr Cr 81896285
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,201
    Operating Expenses Annual Cr 919
    Operating Profit Annual in Cr 272
    Depreciation Cr 53
    Interest Annual Cr 13
    Tax Annual Cr 52
    Net Profit Annual Cr 164
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 237
    Cash from Investing Activity Annual Cr -61
    Cash from Financing Annual Activity Cr -136
    Net Cash Flow Annual Cr 40
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 994
    Fixed Assets Annual Cr 519
    Total Non Current Assets Annual Cr 819
    Total Current Assets Annual Cr 761
    Total Assets Annual Cr 1,580
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 771
    ROE Annual % 16
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 24
    Sign Up to Know More
    Invest in Neuland Laboratories

    Neuland Laboratories Technicals

    EMA & SMA

    Current Price
    ₹6,973.4
    -118.75 (-1.67%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹6,922.17
    • 50 Day
    • ₹6,610.50
    • 100 Day
    • ₹6,124.40
    • 200 Day
    • ₹5,225.46
    • 20 Day
    • ₹6,800.18
    • 50 Day
    • ₹6,702.78
    • 100 Day
    • ₹6,160.56
    • 200 Day
    • ₹5,053.78

    Neuland Laboratories Resistance and Support

    PIVOT
    ₹6,994.77
    Resistance
    First Resistance 7,171.08
    Second Resistance 7,368.77
    Third Resistance 7,545.08
    RSI 52.78
    MFI 66.04
    MACD Single Line 203.88
    MACD 235.09
    Support
    First Resistance 6,797.08
    Second Resistance 6,620.77
    Third Resistance 6,423.08

    Neuland Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 33,392 1,804,170 54.03
    Week 28,324 1,551,327 54.77
    1 Month 41,414 2,082,729 50.29
    6 Month 57,174 3,353,265 58.65

    Neuland Laboratories Result Highlights

    Neuland Laboratories Synopsis

    NSE-Medical-Diversified

    Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1191.20 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2023. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
    Market Cap 8,947
    Sales 1,581
    Shares in Float 0.86
    No of funds 175
    Yield 0.14
    Book Value 9.11
    U/D Vol ratio 1.4
    LTDebt / Equity 8
    Alpha 0.41
    Beta 0.98

    Neuland Laboratories

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 32.74%32.8%35.97%36.03%
    Mutual Funds 3.88%1.83%1.94%1.57%
    Foreign Portfolio Investors 24.43%22.69%21.57%20.19%
    Individual Investors 27.97%29.52%27.86%29.01%
    Others 10.98%13.16%12.66%13.2%

    Neuland Laboratories Management

    Name Designation
    Dr. Davuluri Rama Mohan Rao Executive Chairman
    Mr. Davuluri Sucheth Rao Vice Chairman & CEO
    Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
    Dr. Christopher M Cimarusti Non Executive Director
    Mr. Humayun Dhanrajgir Ind. Non-Executive Director
    Mrs. Bharati Rao Ind. Non-Executive Director
    Dr. Nirmala Murthy Ind. Non-Executive Director
    Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
    Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director
    Mr. Prasad Raghava Menon Ind. Non-Executive Director

    Neuland Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Neuland Laboratories Corporate Action

    Date Purpose Remarks
    2024-05-10 Audited Results & Final Dividend
    2024-02-08 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-03 Quarterly Results
    2023-05-11 Audited Results & Final Dividend
    Date Purpose Remarks
    2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

    Neuland Laboratories MF Shareholding

    Name Amount(cr)
    HSBC Small Cap Fund Fund Regular Growth 13,401
    Bandhan Small Cap Fund Regular Growth 4,385
    WhiteOak Capital Flexi Cap Fund Regular Growth 3,237
    HSBC Multi Cap Fund Regular Growth 2,670
    Bajaj Finserv Flexi Cap Fund Regular Growth 2,439

    Neuland Laboratories FAQs

    What is Share Price of Neuland Laboratories ?

    Neuland Laboratories share price is ₹6,973 As on 28 April, 2024 | 04:42

    What is the Market Cap of Neuland Laboratories ?

    The Market Cap of Neuland Laboratories is ₹8946.8 Cr As on 28 April, 2024 | 04:42

    What is the P/E ratio of Neuland Laboratories ?

    The P/E ratio of Neuland Laboratories is 28.2 As on 28 April, 2024 | 04:42

    What is the PB ratio of Neuland Laboratories ?

    The PB ratio of Neuland Laboratories is 9.1 As on 28 April, 2024 | 04:42

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.